Minerva Endocrinologica 2002 June;27(2)

ORIGINAL ARTICLES  

Minerva Endocrinologica 2002 June;27(2):59-64

Growth disorders in Down’s syndrome: growth hormone treatment

Pallotti S., Giuliano S., Giambi C.

Abstract PDF

ORIGINAL ARTICLES  

Minerva Endocrinologica 2002 June;27(2):65-72

Prevalence and aggressivenes of thyroid carcinoma with diameter less than one centimetre in iodine deficiency areas

Cappelli C., Agosti B., Tironi A., Morassi M. L., Pelizzari G., Cumetti D., Cerudelli B.

Abstract PDF

ORIGINAL ARTICLES  

Minerva Endocrinologica 2002 June;27(2):73-8

Melatonin/circadian rhythm. Is there a feedback between epiphysis and hypophysis?

Pallotti S., Nordio M., Giuliano S.

Abstract PDF

REVIEWS  

Minerva Endocrinologica 2002 June;27(2):79-94

The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent

Lam N. T., Kieffer T. J.

Abstract PDF

REVIEWS  

Minerva Endocrinologica 2002 June;27(2):95-118

Biochemical and imaging evaluation of Cushing’s syndrome

Newell-Price J., Grossman A.

Abstract PDF

REVIEWS  

Minerva Endocrinologica 2002 June;27(2):119-26

The management of thyrotoxicosis: a schematic approach

Papi G., Carapezzi C., Corsello S. M.

Abstract PDF

REVIEWS  

Minerva Endocrinologica 2002 June;27(2):127-40

Tamoxifen, raloxifene and the prevention of breast cancer

Bentrem D. J., Craig Jordan V.

Abstract PDF